DEALBOOK HIGHLIGHTS
Novartis to Buy Multiple Sclerosis Drug From Glaxo The experimental drug ofatumumab would bolster the Swiss pharmaceutical company's portfolio of multiple sclerosis treatments.
Vague Disclosures by Highflying Mutual Funds May Put Investors in Peril Leveraged loans, a kind of obligation held by floating-rate income funds, carry risks that are often not fully disclosed to investors.
Why Jeff Bezos Should Care More for Amazon's EmployeesWorking long and continuous hours isn't a prescription for higher productivity, much less higher quality or more innovation.
Getting Workaholics to Stop and Recharge Americans are taking less time off than ever, studies find, but nonstop workers who find ways to decompress can enjoy physical and mental benefits.
ABN Amro Nearly Doubles Earnings The state-owned Dutch bank posted second-quarter earnings of 600 million euros.
How Ben & Jerry's Social Mission Survived Being Gobbled Up Despite a rocky start, Unilever's acquisition of the ice cream maker became a case study in how small companies can maintain their identities inside conglomerates.
Nema komentara:
Objavi komentar